197 related articles for article (PubMed ID: 29940880)
21. Availability, cost and affordability of essential cardiovascular disease medicines in the south west region of Cameroon: Preliminary findings from the Cameroon science for disease study.
Dzudie A; Njume E; Abanda M; Aminde L; Hamadou B; Dzekem B; Azabji M; Doualla MS; Ngowe M; Kengne AP
PLoS One; 2020; 15(3):e0229307. PubMed ID: 32130252
[TBL] [Abstract][Full Text] [Related]
22. Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria.
Orubu ESF; Robert FO; Samuel M; Megbule D
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii20-iii26. PubMed ID: 31816074
[TBL] [Abstract][Full Text] [Related]
23. Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening.
Tran DN; Njuguna B; Mercer T; Manji I; Fischer L; Lieberman M; Pastakia SD
Cardiol Clin; 2017 Feb; 35(1):125-134. PubMed ID: 27886782
[TBL] [Abstract][Full Text] [Related]
24. Access to diagnostic tests and essential medicines for cardiovascular diseases and diabetes care: cost, availability and affordability in the West Region of Cameroon.
Jingi AM; Noubiap JJ; Ewane Onana A; Nansseu JR; Wang B; Kingue S; Kengne AP
PLoS One; 2014; 9(11):e111812. PubMed ID: 25369455
[TBL] [Abstract][Full Text] [Related]
25. Mapping actions to improve access to medicines for mental disorders in low and middle income countries.
Barbui C; Dua T; Kolappa K; Saraceno B; Saxena S
Epidemiol Psychiatr Sci; 2017 Oct; 26(5):481-490. PubMed ID: 28067194
[TBL] [Abstract][Full Text] [Related]
26. Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.
Twagirumukiza M; Annemans L; Kips JG; Bienvenu E; Van Bortel LM
Trop Med Int Health; 2010 Mar; 15(3):350-61. PubMed ID: 20070634
[TBL] [Abstract][Full Text] [Related]
27. Impact of pharmaceutical price controls on the cost of cardiovascular drugs: does essentiality matter?
Khanijo S; Kakkar AK; Kumar R; Patil AN; Bhusal G; Vishwas G; Arora G
Expert Rev Clin Pharmacol; 2020 Jul; 13(7):797-806. PubMed ID: 32552127
[TBL] [Abstract][Full Text] [Related]
28. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
29. Increasing access to quality anticancer medicines in low- and middle-income countries: the experience of Uganda.
Osinde G; Niyonzima N; Mulema V; Kyambadde D; Mulumba Y; Obayo S; Anecho E; Watera S; Constance M; Kadhumbula S; Orem J
Future Oncol; 2021 Jul; 17(21):2735-2745. PubMed ID: 33855863
[TBL] [Abstract][Full Text] [Related]
30. Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.
Walli-Attaei M; Joseph P; Rosengren A; Chow CK; Rangarajan S; Lear SA; AlHabib KF; Davletov K; Dans A; Lanas F; Yeates K; Poirier P; Teo KK; Bahonar A; Camilo F; Chifamba J; Diaz R; Didkowska JA; Irazola V; Ismail R; Kaur M; Khatib R; Liu X; Mańczuk M; Miranda JJ; Oguz A; Perez-Mayorga M; Szuba A; Tsolekile LP; Prasad Varma R; Yusufali A; Yusuf R; Wei L; Anand SS; Yusuf S
Lancet; 2020 Jul; 396(10244):97-109. PubMed ID: 32445693
[TBL] [Abstract][Full Text] [Related]
31. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
[TBL] [Abstract][Full Text] [Related]
32. Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.
Kishore SP; Blank E; Heller DJ; Patel A; Peters A; Price M; Vidula M; Fuster V; Onuma O; Huffman MD; Vedanthan R
J Am Coll Cardiol; 2018 Feb; 71(5):564-574. PubMed ID: 29406862
[TBL] [Abstract][Full Text] [Related]
33. Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists.
Jarvis JD; Woods H; Bali A; Oronsaye E; Persaud N
PLoS One; 2019; 14(8):e0220781. PubMed ID: 31398195
[TBL] [Abstract][Full Text] [Related]
34. Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region.
Mehrtash H; Laing R; Wirtz VJ
East Mediterr Health J; 2018 Jul; 24(5):427-434. PubMed ID: 30043961
[TBL] [Abstract][Full Text] [Related]
35. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.
Mendis S; Fukino K; Cameron A; Laing R; Filipe A; Khatib O; Leowski J; Ewen M
Bull World Health Organ; 2007 Apr; 85(4):279-88. PubMed ID: 17546309
[TBL] [Abstract][Full Text] [Related]
36. Essential cancer medicines and cancer outcomes: Cross-sectional study of 124 countries.
Ikpeni OT; Maraj D; Woods H; Workentin A; Booth CM; Persaud N
Cancer Med; 2023 Nov; 12(22):20745-20758. PubMed ID: 37902259
[TBL] [Abstract][Full Text] [Related]
37. Access to medicines and diagnostic tests integral in the management of diabetes mellitus and cardiovascular diseases in Uganda: insights from the ACCODAD study.
Kibirige D; Atuhe D; Kampiire L; Kiggundu DS; Donggo P; Nabbaale J; Mwebaze RM; Kalyesubula R; Lumu W
Int J Equity Health; 2017 Aug; 16(1):154. PubMed ID: 28836972
[TBL] [Abstract][Full Text] [Related]
38. Pain Treatment Continues To Be Inaccessible for Many Patients Around the Globe: Second Phase of Opioid Price Watch, a Cross-Sectional Study To Monitor the Prices of Opioids.
Pastrana T; Wenk R; Radbruch L; Ahmed E; De Lima L
J Palliat Med; 2017 Apr; 20(4):378-387. PubMed ID: 27923102
[TBL] [Abstract][Full Text] [Related]
39. Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?
Noubiap JJ; Nansseu JR
Vasc Health Risk Manag; 2015; 11():503-6. PubMed ID: 26345154
[TBL] [Abstract][Full Text] [Related]
40. Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines?
Srivastava D; McGuire A
BMC Public Health; 2014 Jul; 14():767. PubMed ID: 25073407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
